Skip to Main content Skip to Navigation
Journal articles

Metabolomics evaluation of repeated administration of potassium iodide on adult male rats

Abstract : The long-lasting consequence of a new iodine thyroid blocking strategy (ITB) to be used in case of nuclear accident is evaluated in male Wistar rats using a metabolomics approach applied 30 days after ITB completion. The design used 1 mg/kg/day of KI over 8 days. Thyroid hormones remained unchanged, but there was a metabolic shift measured mainly in thyroid then in plasma and urine. In the thyroid, tyrosine metabolism associated to catecholamine metabolism was more clearly impacted than thyroid hormones pathway. It was accompanied by a peripheral metabolic shift including metabolic regulators, branched-chain amino acids, oxidant stress and inflammation-associated response. Our results suggested that iodide intake can impact gut microbiota metabolism, which was related to host metabolic regulations including in the thyroid. As there were no clear clinical signs of dysfunction or toxicity, we concluded that the measured metabolomics response to the new ITB strategy, especially in thyroid, is unlikely to reveal a pathological condition but a shift towards a new adaptive homeostatic state, called 'allostatic regulation'. The question now is whether or not the shift is permanent and if so at what cost for long-term health. We anticipate our data as a start point for further regulatory toxicity studies.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03159938
Contributor : Nelly Lucas <>
Submitted on : Monday, May 17, 2021 - 5:13:05 PM
Last modification on : Monday, May 17, 2021 - 5:13:05 PM

Identifiers

Collections

Citation

Clément Rosique, Dalila Lebsir, Sheherazade Benatia, Pierre Guigon, François Caire-Maurisier, et al.. Metabolomics evaluation of repeated administration of potassium iodide on adult male rats. Archives of Toxicology, Springer Verlag, 2020, 94 (3), pp.803-812. ⟨10.1007/s00204-020-02666-w⟩. ⟨hal-03159938⟩

Share

Metrics

Record views

39